JAK3/BTK-IN-3 is a potent JAK3/BTK inhibitor with potential for the study of JAK3 kinase- and/or BTK-related diseases, particularly autoimmune disorders, by simultaneously inhibiting the BTK/JAK3 signaling pathways, which demonstrates synergistic effects.